Frontlight ResearchEarly access
Trial site
Fort Lauderdale
- 16running trials
- 3closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease4 trials
- Lung cancer3 trials
- Heart failure2 trials
- High blood pressure2 trials
- Systemic sclerosis (scleroderma)2 trials
- Atrial fibrillation1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- COPD1 trial
- Coronary artery disease1 trial
- Endometrial cancer1 trial
- Lupus (SLE)1 trial
- and 6 more
- Phase
- Phase 317 trials
- Phase 21 trial
- Status
- Recruiting7 trials
- Active, not recruiting5 trials
- Not yet recruiting4 trials
- Completed1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- AstraZeneca18 trials
- DalCor Pharmaceuticals1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease3 recruiting
- Lung cancer2 recruiting
- COPD1 recruiting
- Coronary artery disease1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Lupus (SLE)1 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Recruiting
Completed
Terminated
Site data: ClinicalTrials.govUpdated 13 Nov 2026